Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China

Background In December 2019, coronavirus disease 2019 (COVID-19) outbreak was reported from Wuhan, China. Information on the clinical course and prognosis of COVID-19 was not thoroughly described. We described the clinical courses and prognosis in COVID-19 patients. Methods Retrospective case series...

Full description

Saved in:
Bibliographic Details
Published in:Critical care (London, England) Vol. 24; no. 1; pp. 188 - 9
Main Authors: Wang, Dawei, Yin, Yimei, Hu, Chang, Liu, Xing, Zhang, Xingguo, Zhou, Shuliang, Jian, Mingzhi, Xu, Haibo, Prowle, John, Hu, Bo, Li, Yirong, Peng, Zhiyong
Format: Journal Article
Language:English
Published: London BioMed Central 30.04.2020
BioMed Central Ltd
Springer Nature B.V
BMC
Subjects:
ISSN:1364-8535, 1466-609X, 1364-8535, 1466-609X, 1366-609X
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background In December 2019, coronavirus disease 2019 (COVID-19) outbreak was reported from Wuhan, China. Information on the clinical course and prognosis of COVID-19 was not thoroughly described. We described the clinical courses and prognosis in COVID-19 patients. Methods Retrospective case series of COVID-19 patients from Zhongnan Hospital of Wuhan University in Wuhan and Xishui Hospital, Hubei Province, China, up to February 10, 2020. Epidemiological, demographic, and clinical data were collected. The clinical course of survivors and non-survivors were compared. Risk factors for death were analyzed. Results A total of 107 discharged patients with COVID-19 were enrolled. The clinical course of COVID-19 presented as a tri-phasic pattern. Week 1 after illness onset was characterized by fever, cough, dyspnea, lymphopenia, and radiological multi-lobar pulmonary infiltrates. In severe cases, thrombocytopenia, acute kidney injury, acute myocardial injury, and adult respiratory distress syndrome were observed. During week 2, in mild cases, fever, cough, and systemic symptoms began to resolve and platelet count rose to normal range, but lymphopenia persisted. In severe cases, leukocytosis, neutrophilia, and deteriorating multi-organ dysfunction were dominant. By week 3, mild cases had clinically resolved except for lymphopenia. However, severe cases showed persistent lymphopenia, severe acute respiratory dyspnea syndrome, refractory shock, anuric acute kidney injury, coagulopathy, thrombocytopenia, and death. Older age and male sex were independent risk factors for poor outcome of the illness. Conclusions A period of 7–13 days after illness onset is the critical stage in the COVID-19 course. Age and male gender were independent risk factors for death of COVID-19.
AbstractList Background In December 2019, coronavirus disease 2019 (COVID-19) outbreak was reported from Wuhan, China. Information on the clinical course and prognosis of COVID-19 was not thoroughly described. We described the clinical courses and prognosis in COVID-19 patients. Methods Retrospective case series of COVID-19 patients from Zhongnan Hospital of Wuhan University in Wuhan and Xishui Hospital, Hubei Province, China, up to February 10, 2020. Epidemiological, demographic, and clinical data were collected. The clinical course of survivors and non-survivors were compared. Risk factors for death were analyzed. Results A total of 107 discharged patients with COVID-19 were enrolled. The clinical course of COVID-19 presented as a tri-phasic pattern. Week 1 after illness onset was characterized by fever, cough, dyspnea, lymphopenia, and radiological multi-lobar pulmonary infiltrates. In severe cases, thrombocytopenia, acute kidney injury, acute myocardial injury, and adult respiratory distress syndrome were observed. During week 2, in mild cases, fever, cough, and systemic symptoms began to resolve and platelet count rose to normal range, but lymphopenia persisted. In severe cases, leukocytosis, neutrophilia, and deteriorating multi-organ dysfunction were dominant. By week 3, mild cases had clinically resolved except for lymphopenia. However, severe cases showed persistent lymphopenia, severe acute respiratory dyspnea syndrome, refractory shock, anuric acute kidney injury, coagulopathy, thrombocytopenia, and death. Older age and male sex were independent risk factors for poor outcome of the illness. Conclusions A period of 7–13 days after illness onset is the critical stage in the COVID-19 course. Age and male gender were independent risk factors for death of COVID-19.
In December 2019, coronavirus disease 2019 (COVID-19) outbreak was reported from Wuhan, China. Information on the clinical course and prognosis of COVID-19 was not thoroughly described. We described the clinical courses and prognosis in COVID-19 patients. Retrospective case series of COVID-19 patients from Zhongnan Hospital of Wuhan University in Wuhan and Xishui Hospital, Hubei Province, China, up to February 10, 2020. Epidemiological, demographic, and clinical data were collected. The clinical course of survivors and non-survivors were compared. Risk factors for death were analyzed. A total of 107 discharged patients with COVID-19 were enrolled. The clinical course of COVID-19 presented as a tri-phasic pattern. Week 1 after illness onset was characterized by fever, cough, dyspnea, lymphopenia, and radiological multi-lobar pulmonary infiltrates. In severe cases, thrombocytopenia, acute kidney injury, acute myocardial injury, and adult respiratory distress syndrome were observed. During week 2, in mild cases, fever, cough, and systemic symptoms began to resolve and platelet count rose to normal range, but lymphopenia persisted. In severe cases, leukocytosis, neutrophilia, and deteriorating multi-organ dysfunction were dominant. By week 3, mild cases had clinically resolved except for lymphopenia. However, severe cases showed persistent lymphopenia, severe acute respiratory dyspnea syndrome, refractory shock, anuric acute kidney injury, coagulopathy, thrombocytopenia, and death. Older age and male sex were independent risk factors for poor outcome of the illness. A period of 7-13 days after illness onset is the critical stage in the COVID-19 course. Age and male gender were independent risk factors for death of COVID-19.
In December 2019, coronavirus disease 2019 (COVID-19) outbreak was reported from Wuhan, China. Information on the clinical course and prognosis of COVID-19 was not thoroughly described. We described the clinical courses and prognosis in COVID-19 patients. Retrospective case series of COVID-19 patients from Zhongnan Hospital of Wuhan University in Wuhan and Xishui Hospital, Hubei Province, China, up to February 10, 2020. Epidemiological, demographic, and clinical data were collected. The clinical course of survivors and non-survivors were compared. Risk factors for death were analyzed. A total of 107 discharged patients with COVID-19 were enrolled. The clinical course of COVID-19 presented as a tri-phasic pattern. Week 1 after illness onset was characterized by fever, cough, dyspnea, lymphopenia, and radiological multi-lobar pulmonary infiltrates. In severe cases, thrombocytopenia, acute kidney injury, acute myocardial injury, and adult respiratory distress syndrome were observed. During week 2, in mild cases, fever, cough, and systemic symptoms began to resolve and platelet count rose to normal range, but lymphopenia persisted. In severe cases, leukocytosis, neutrophilia, and deteriorating multi-organ dysfunction were dominant. By week 3, mild cases had clinically resolved except for lymphopenia. However, severe cases showed persistent lymphopenia, severe acute respiratory dyspnea syndrome, refractory shock, anuric acute kidney injury, coagulopathy, thrombocytopenia, and death. Older age and male sex were independent risk factors for poor outcome of the illness. A period of 7-13 days after illness onset is the critical stage in the COVID-19 course. Age and male gender were independent risk factors for death of COVID-19.
Abstract Background In December 2019, coronavirus disease 2019 (COVID-19) outbreak was reported from Wuhan, China. Information on the clinical course and prognosis of COVID-19 was not thoroughly described. We described the clinical courses and prognosis in COVID-19 patients. Methods Retrospective case series of COVID-19 patients from Zhongnan Hospital of Wuhan University in Wuhan and Xishui Hospital, Hubei Province, China, up to February 10, 2020. Epidemiological, demographic, and clinical data were collected. The clinical course of survivors and non-survivors were compared. Risk factors for death were analyzed. Results A total of 107 discharged patients with COVID-19 were enrolled. The clinical course of COVID-19 presented as a tri-phasic pattern. Week 1 after illness onset was characterized by fever, cough, dyspnea, lymphopenia, and radiological multi-lobar pulmonary infiltrates. In severe cases, thrombocytopenia, acute kidney injury, acute myocardial injury, and adult respiratory distress syndrome were observed. During week 2, in mild cases, fever, cough, and systemic symptoms began to resolve and platelet count rose to normal range, but lymphopenia persisted. In severe cases, leukocytosis, neutrophilia, and deteriorating multi-organ dysfunction were dominant. By week 3, mild cases had clinically resolved except for lymphopenia. However, severe cases showed persistent lymphopenia, severe acute respiratory dyspnea syndrome, refractory shock, anuric acute kidney injury, coagulopathy, thrombocytopenia, and death. Older age and male sex were independent risk factors for poor outcome of the illness. Conclusions A period of 7–13 days after illness onset is the critical stage in the COVID-19 course. Age and male gender were independent risk factors for death of COVID-19.
In December 2019, coronavirus disease 2019 (COVID-19) outbreak was reported from Wuhan, China. Information on the clinical course and prognosis of COVID-19 was not thoroughly described. We described the clinical courses and prognosis in COVID-19 patients.BACKGROUNDIn December 2019, coronavirus disease 2019 (COVID-19) outbreak was reported from Wuhan, China. Information on the clinical course and prognosis of COVID-19 was not thoroughly described. We described the clinical courses and prognosis in COVID-19 patients.Retrospective case series of COVID-19 patients from Zhongnan Hospital of Wuhan University in Wuhan and Xishui Hospital, Hubei Province, China, up to February 10, 2020. Epidemiological, demographic, and clinical data were collected. The clinical course of survivors and non-survivors were compared. Risk factors for death were analyzed.METHODSRetrospective case series of COVID-19 patients from Zhongnan Hospital of Wuhan University in Wuhan and Xishui Hospital, Hubei Province, China, up to February 10, 2020. Epidemiological, demographic, and clinical data were collected. The clinical course of survivors and non-survivors were compared. Risk factors for death were analyzed.A total of 107 discharged patients with COVID-19 were enrolled. The clinical course of COVID-19 presented as a tri-phasic pattern. Week 1 after illness onset was characterized by fever, cough, dyspnea, lymphopenia, and radiological multi-lobar pulmonary infiltrates. In severe cases, thrombocytopenia, acute kidney injury, acute myocardial injury, and adult respiratory distress syndrome were observed. During week 2, in mild cases, fever, cough, and systemic symptoms began to resolve and platelet count rose to normal range, but lymphopenia persisted. In severe cases, leukocytosis, neutrophilia, and deteriorating multi-organ dysfunction were dominant. By week 3, mild cases had clinically resolved except for lymphopenia. However, severe cases showed persistent lymphopenia, severe acute respiratory dyspnea syndrome, refractory shock, anuric acute kidney injury, coagulopathy, thrombocytopenia, and death. Older age and male sex were independent risk factors for poor outcome of the illness.RESULTSA total of 107 discharged patients with COVID-19 were enrolled. The clinical course of COVID-19 presented as a tri-phasic pattern. Week 1 after illness onset was characterized by fever, cough, dyspnea, lymphopenia, and radiological multi-lobar pulmonary infiltrates. In severe cases, thrombocytopenia, acute kidney injury, acute myocardial injury, and adult respiratory distress syndrome were observed. During week 2, in mild cases, fever, cough, and systemic symptoms began to resolve and platelet count rose to normal range, but lymphopenia persisted. In severe cases, leukocytosis, neutrophilia, and deteriorating multi-organ dysfunction were dominant. By week 3, mild cases had clinically resolved except for lymphopenia. However, severe cases showed persistent lymphopenia, severe acute respiratory dyspnea syndrome, refractory shock, anuric acute kidney injury, coagulopathy, thrombocytopenia, and death. Older age and male sex were independent risk factors for poor outcome of the illness.A period of 7-13 days after illness onset is the critical stage in the COVID-19 course. Age and male gender were independent risk factors for death of COVID-19.CONCLUSIONSA period of 7-13 days after illness onset is the critical stage in the COVID-19 course. Age and male gender were independent risk factors for death of COVID-19.
Background In December 2019, coronavirus disease 2019 (COVID-19) outbreak was reported from Wuhan, China. Information on the clinical course and prognosis of COVID-19 was not thoroughly described. We described the clinical courses and prognosis in COVID-19 patients. Methods Retrospective case series of COVID-19 patients from Zhongnan Hospital of Wuhan University in Wuhan and Xishui Hospital, Hubei Province, China, up to February 10, 2020. Epidemiological, demographic, and clinical data were collected. The clinical course of survivors and non-survivors were compared. Risk factors for death were analyzed. Results A total of 107 discharged patients with COVID-19 were enrolled. The clinical course of COVID-19 presented as a tri-phasic pattern. Week 1 after illness onset was characterized by fever, cough, dyspnea, lymphopenia, and radiological multi-lobar pulmonary infiltrates. In severe cases, thrombocytopenia, acute kidney injury, acute myocardial injury, and adult respiratory distress syndrome were observed. During week 2, in mild cases, fever, cough, and systemic symptoms began to resolve and platelet count rose to normal range, but lymphopenia persisted. In severe cases, leukocytosis, neutrophilia, and deteriorating multi-organ dysfunction were dominant. By week 3, mild cases had clinically resolved except for lymphopenia. However, severe cases showed persistent lymphopenia, severe acute respiratory dyspnea syndrome, refractory shock, anuric acute kidney injury, coagulopathy, thrombocytopenia, and death. Older age and male sex were independent risk factors for poor outcome of the illness. Conclusions A period of 7-13 days after illness onset is the critical stage in the COVID-19 course. Age and male gender were independent risk factors for death of COVID-19. Keywords: Coronavirus, Infection, Pneumonia
Background In December 2019, coronavirus disease 2019 (COVID-19) outbreak was reported from Wuhan, China. Information on the clinical course and prognosis of COVID-19 was not thoroughly described. We described the clinical courses and prognosis in COVID-19 patients. Methods Retrospective case series of COVID-19 patients from Zhongnan Hospital of Wuhan University in Wuhan and Xishui Hospital, Hubei Province, China, up to February 10, 2020. Epidemiological, demographic, and clinical data were collected. The clinical course of survivors and non-survivors were compared. Risk factors for death were analyzed. Results A total of 107 discharged patients with COVID-19 were enrolled. The clinical course of COVID-19 presented as a tri-phasic pattern. Week 1 after illness onset was characterized by fever, cough, dyspnea, lymphopenia, and radiological multi-lobar pulmonary infiltrates. In severe cases, thrombocytopenia, acute kidney injury, acute myocardial injury, and adult respiratory distress syndrome were observed. During week 2, in mild cases, fever, cough, and systemic symptoms began to resolve and platelet count rose to normal range, but lymphopenia persisted. In severe cases, leukocytosis, neutrophilia, and deteriorating multi-organ dysfunction were dominant. By week 3, mild cases had clinically resolved except for lymphopenia. However, severe cases showed persistent lymphopenia, severe acute respiratory dyspnea syndrome, refractory shock, anuric acute kidney injury, coagulopathy, thrombocytopenia, and death. Older age and male sex were independent risk factors for poor outcome of the illness. Conclusions A period of 7–13 days after illness onset is the critical stage in the COVID-19 course. Age and male gender were independent risk factors for death of COVID-19.
ArticleNumber 188
Audience Academic
Author Yin, Yimei
Prowle, John
Wang, Dawei
Liu, Xing
Jian, Mingzhi
Li, Yirong
Hu, Chang
Peng, Zhiyong
Zhou, Shuliang
Zhang, Xingguo
Hu, Bo
Xu, Haibo
Author_xml – sequence: 1
  givenname: Dawei
  surname: Wang
  fullname: Wang, Dawei
  organization: Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University
– sequence: 2
  givenname: Yimei
  surname: Yin
  fullname: Yin, Yimei
  organization: Department of Ultrasound Medicine, Zhongnan Hospital of Wuhan University
– sequence: 3
  givenname: Chang
  surname: Hu
  fullname: Hu, Chang
  organization: Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University
– sequence: 4
  givenname: Xing
  surname: Liu
  fullname: Liu, Xing
  organization: Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University
– sequence: 5
  givenname: Xingguo
  surname: Zhang
  fullname: Zhang, Xingguo
  organization: Department of Critical Care Medicine, Xishui Hospital
– sequence: 6
  givenname: Shuliang
  surname: Zhou
  fullname: Zhou, Shuliang
  organization: Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University
– sequence: 7
  givenname: Mingzhi
  surname: Jian
  fullname: Jian, Mingzhi
  organization: Department of Health Education, Center for Disease Control and Prevention
– sequence: 8
  givenname: Haibo
  surname: Xu
  fullname: Xu, Haibo
  organization: Department of Radiology, Zhongnan Hospital of Wuhan University
– sequence: 9
  givenname: John
  surname: Prowle
  fullname: Prowle, John
  organization: Adult Critical Care Unit, The Royal London Hospital, Barts Health NHS Trust
– sequence: 10
  givenname: Bo
  surname: Hu
  fullname: Hu, Bo
  organization: Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University
– sequence: 11
  givenname: Yirong
  surname: Li
  fullname: Li, Yirong
  email: liyirong838@163.com
  organization: Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University
– sequence: 12
  givenname: Zhiyong
  surname: Peng
  fullname: Peng, Zhiyong
  email: Pengzy5@hotmail.com
  organization: Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32354360$$D View this record in MEDLINE/PubMed
BookMark eNp9Ustq3DAUNSWlebQ_0EURdJPFONXLsrUpDEMfgUCh6WMpZFkaK3ikqWRP6C_0q3snkzSZUIIwMtfnnOtz7zkuDkIMtiheE3xGSCPeZcJwxUtMMTyNrErxrDgiTPCyqVh18OD9sDjO-QpjUjeCvSgOGWUVZwIfFX8Wgw_e6AGZOKVskQ4ditNo4sqi6BDBNVrr0dswZuSDs2a0Hbr2Y4_G3qIQN3ZLTTHojU9TnqHL-dfLchF_lHSGOp9Nr9MSKC7FFRqvI-pjXvtRD1s59HPqdZihRe-Dflk8d1C2r27vk-L7xw_fFp_Liy-fzhfzi9IIXI8lFYxr3ZJOOEu1k4LLllHMDeG6I7glba07WUnadrbuHG8r2TS4dg5L1vKas5PifKfbRX2l1smvdPqtovbqphDTUuk0ejNYZXkjoQOtGe64EwYUTCW1lJLW1mENWu93WuupXdnOwJiSHvZE978E36tl3KiaSFqJ7c-c3gqk-GuyeVQrmJkdBh1snLKiTNaiASQG6NtH0CtYWYBRKcoxp5xTzO5RSw0GYGMR-pqtqJqDEU5ZUzWAOvsPCk5nV95AzJyH-h7hzUOj_xzeJQkAzQ5gUsw5WacMbHn0cevbD4pgtQ2t2oVWQWjVTWiVACp9RL1Tf5LEdqQM4LC06X4aT7D-AjuB_NA
CitedBy_id crossref_primary_10_1111_tid_13539
crossref_primary_10_1186_s13054_020_03065_4
crossref_primary_10_3390_diagnostics12020509
crossref_primary_10_3390_vaccines10122043
crossref_primary_10_1080_0092623X_2021_2000535
crossref_primary_10_1111_all_14647
crossref_primary_10_1161_JAHA_121_021046
crossref_primary_10_1186_s43163_021_00186_7
crossref_primary_10_3389_fimmu_2021_801410
crossref_primary_10_3390_diseases8040041
crossref_primary_10_1007_s42399_020_00515_6
crossref_primary_10_1097_PHH_0000000000001257
crossref_primary_10_1016_j_clnesp_2021_03_012
crossref_primary_10_1080_07853890_2020_1790643
crossref_primary_10_1186_s13054_020_03260_3
crossref_primary_10_1007_s12640_021_00389_z
crossref_primary_10_1111_all_14657
crossref_primary_10_1186_s13054_020_03077_0
crossref_primary_10_3201_eid2705_204507
crossref_primary_10_14814_phy2_14800
crossref_primary_10_1111_imj_15140
crossref_primary_10_1371_journal_pcbi_1008451
crossref_primary_10_1002_clc_23540
crossref_primary_10_7189_jogh_11_10001
crossref_primary_10_31146_1682_8658_ecg_179_7_143_151
crossref_primary_10_3390_v17030429
crossref_primary_10_1080_13813455_2020_1856141
crossref_primary_10_3390_pathogens9121052
crossref_primary_10_1017_S0950268821000376
crossref_primary_10_1186_s13054_021_03504_w
crossref_primary_10_3390_ijerph191912203
crossref_primary_10_1097_MD_0000000000032919
crossref_primary_10_1155_2020_3280908
crossref_primary_10_1080_07853890_2022_2054026
crossref_primary_10_1080_17434440_2021_1915764
crossref_primary_10_1016_j_thromres_2020_08_017
crossref_primary_10_3389_fmed_2021_588013
crossref_primary_10_1016_j_numecd_2020_09_004
crossref_primary_10_1080_21645515_2024_2324549
crossref_primary_10_1016_j_intimp_2020_107159
crossref_primary_10_7554_eLife_63195
crossref_primary_10_3389_fped_2020_607647
crossref_primary_10_3390_jcm9051371
crossref_primary_10_1371_journal_pone_0241541
crossref_primary_10_3390_cancers13246294
crossref_primary_10_1186_s12879_022_07031_z
crossref_primary_10_1186_s13054_020_02992_6
crossref_primary_10_7759_cureus_14279
crossref_primary_10_1371_journal_pone_0249655
crossref_primary_10_3390_ijerph17218049
crossref_primary_10_1016_j_mayocp_2020_10_022
crossref_primary_10_1016_j_csbj_2020_12_033
crossref_primary_10_1111_ijlh_13298
crossref_primary_10_1097_SHK_0000000000001738
crossref_primary_10_1007_s00405_021_06900_8
crossref_primary_10_3389_fphar_2020_570721
crossref_primary_10_3390_pathogens11050563
crossref_primary_10_4081_mrm_2020_713
crossref_primary_10_1007_s10072_020_04801_y
crossref_primary_10_1016_j_ajem_2020_10_022
crossref_primary_10_1126_scitranslmed_abj7790
crossref_primary_10_1016_j_ajem_2020_10_013
crossref_primary_10_1183_13993003_02108_2020
crossref_primary_10_1111_ans_16260
crossref_primary_10_1108_JICA_08_2023_0066
crossref_primary_10_1186_s12879_020_05252_8
crossref_primary_10_1186_s40001_021_00513_x
crossref_primary_10_7861_clinmed_21_2_s36
crossref_primary_10_1080_17476348_2020_1804365
crossref_primary_10_3390_jcm9103218
crossref_primary_10_1016_j_clinimag_2021_06_012
crossref_primary_10_1177_09612033241266875
crossref_primary_10_1186_s12882_021_02244_x
crossref_primary_10_1111_dth_13549
crossref_primary_10_1371_journal_pone_0247461
crossref_primary_10_1371_journal_pone_0255154
crossref_primary_10_1002_clc_23465
crossref_primary_10_1016_j_amjcard_2020_06_004
crossref_primary_10_1016_j_sleep_2020_08_010
crossref_primary_10_1093_jleuko_qiaf056
crossref_primary_10_1002_jcla_23412
crossref_primary_10_1016_j_intimp_2020_106950
crossref_primary_10_3389_fphar_2021_607408
crossref_primary_10_1159_000512211
crossref_primary_10_1007_s13318_020_00668_8
crossref_primary_10_4103_jtccm_jtccm_7_21
crossref_primary_10_1007_s00430_020_00696_w
crossref_primary_10_1080_20477724_2022_2160892
crossref_primary_10_3390_ijerph19095099
crossref_primary_10_1155_2021_4303380
crossref_primary_10_1177_2040622321998860
crossref_primary_10_1016_j_ajem_2020_05_063
crossref_primary_10_7748_ns_2021_e11667
crossref_primary_10_1002_rmv_2195
crossref_primary_10_1089_mdr_2020_0619
crossref_primary_10_3390_pathogens10010005
crossref_primary_10_3389_fmed_2020_594495
crossref_primary_10_3390_ijerph19106034
crossref_primary_10_1016_j_cmi_2020_12_018
crossref_primary_10_1111_jdi_13431
crossref_primary_10_2459_JCM_0000000000001064
crossref_primary_10_1097_CRD_0000000000000422
crossref_primary_10_1159_000512209
crossref_primary_10_1016_j_jiph_2022_12_019
crossref_primary_10_7748_nop_2021_e1311
crossref_primary_10_1080_03007995_2020_1853510
crossref_primary_10_12688_f1000research_151333_2
crossref_primary_10_12688_f1000research_151333_1
crossref_primary_10_1007_s10787_022_01050_7
crossref_primary_10_1016_j_dsx_2021_102308
crossref_primary_10_1016_j_jinf_2020_06_060
crossref_primary_10_1016_j_ihj_2020_12_002
crossref_primary_10_1016_j_clineuro_2020_106183
crossref_primary_10_9778_cmajo_20200159
crossref_primary_10_3390_geriatrics6010030
crossref_primary_10_1016_j_phrs_2020_105107
crossref_primary_10_1016_j_avsg_2022_04_048
crossref_primary_10_1186_s12916_021_02058_6
crossref_primary_10_1016_j_ijid_2020_12_023
crossref_primary_10_1016_j_jiph_2021_02_001
crossref_primary_10_1111_ijlh_13381
crossref_primary_10_1111_jocn_15688
crossref_primary_10_1016_j_numecd_2020_12_009
crossref_primary_10_63096_medtigo3062323
crossref_primary_10_1016_j_crmeth_2025_101022
crossref_primary_10_1186_s13054_020_03051_w
crossref_primary_10_5812_ijem_113220
crossref_primary_10_1002_eji_202350433
crossref_primary_10_12873_411cabral
crossref_primary_10_1080_14787210_2021_1902805
crossref_primary_10_34067_KID_0006362020
crossref_primary_10_1371_journal_pone_0241955
crossref_primary_10_1016_j_arcmed_2020_07_005
crossref_primary_10_1177_2151459320972674
crossref_primary_10_24060_2076_3093_202010_3_233_240
crossref_primary_10_3390_microorganisms11030774
crossref_primary_10_1177_20543581211027759
crossref_primary_10_1002_cncr_33160
crossref_primary_10_25122_jml_2021_0341
crossref_primary_10_1007_s11255_020_02740_3
crossref_primary_10_3390_ijerph191911990
crossref_primary_10_1038_s41598_021_90111_y
crossref_primary_10_1186_s13048_020_00734_4
crossref_primary_10_3390_jcm9092685
crossref_primary_10_1016_j_pharmthera_2020_107745
crossref_primary_10_1155_2021_6660930
crossref_primary_10_3389_fimmu_2022_899559
crossref_primary_10_1371_journal_pone_0241827
crossref_primary_10_1111_1744_9987_13895
crossref_primary_10_1111_ijn_13112
crossref_primary_10_3389_fphar_2020_607689
crossref_primary_10_1016_j_jinf_2020_05_024
crossref_primary_10_24171_j_phrp_2021_0186
crossref_primary_10_1136_jim_2020_001555
crossref_primary_10_1038_s41598_021_89182_8
crossref_primary_10_7759_cureus_26771
crossref_primary_10_1111_hdi_12861
crossref_primary_10_1016_j_virol_2022_06_006
crossref_primary_10_3389_fmed_2020_585003
crossref_primary_10_1038_s43856_021_00006_2
crossref_primary_10_1002_edm2_338
crossref_primary_10_13105_wjma_v9_i1_74
crossref_primary_10_3889_oamjms_2023_11583
crossref_primary_10_1007_s10072_020_04978_2
crossref_primary_10_1016_j_imu_2023_101188
crossref_primary_10_1186_s13054_020_03134_8
crossref_primary_10_1016_j_dsx_2020_10_014
crossref_primary_10_3233_HAB_220006
crossref_primary_10_1016_j_jcrc_2020_11_006
crossref_primary_10_1093_cid_ciaa1911
crossref_primary_10_1111_aji_13518
crossref_primary_10_1007_s11739_021_02860_3
crossref_primary_10_37689_acta_ape_2022AO0163345
crossref_primary_10_1186_s41927_020_00165_0
crossref_primary_10_7759_cureus_26909
crossref_primary_10_1017_cjn_2021_148
crossref_primary_10_1016_j_micpath_2020_104504
crossref_primary_10_3390_diagnostics12092144
crossref_primary_10_1155_2023_9529563
crossref_primary_10_1371_journal_pone_0238905
crossref_primary_10_1016_j_hjdsi_2020_100512
crossref_primary_10_1371_journal_pone_0254581
crossref_primary_10_1016_j_ijsu_2022_106830
crossref_primary_10_1155_2022_9119930
crossref_primary_10_1097_ALN_0000000000003521
crossref_primary_10_1016_j_ijid_2021_03_008
crossref_primary_10_3390_jcm9072244
crossref_primary_10_1016_j_cmi_2020_10_017
crossref_primary_10_1590_1806_9282_66_s2_112
crossref_primary_10_4103_jpbs_jpbs_460_21
crossref_primary_10_1016_j_nmni_2021_100905
crossref_primary_10_1155_2023_3505657
crossref_primary_10_1186_s13054_020_03171_3
crossref_primary_10_3389_fnut_2024_1458106
crossref_primary_10_1371_journal_pone_0243124
crossref_primary_10_1016_j_chest_2020_10_054
crossref_primary_10_1016_j_phrs_2020_105250
crossref_primary_10_1097_MD_0000000000023353
crossref_primary_10_1016_j_apmr_2020_11_005
crossref_primary_10_37689_acta_ape_2024AR002532
crossref_primary_10_1136_bmjopen_2020_047033
crossref_primary_10_1111_jan_14558
crossref_primary_10_3390_ijerph17165974
crossref_primary_10_1111_ajt_16280
crossref_primary_10_1186_s13054_020_03009_y
crossref_primary_10_3389_fimmu_2021_710217
Cites_doi 10.1016/S0140-6736(20)30154-9
10.1101/2020.01.30.927806
10.1056/NEJMoa2002032
10.1056/NEJMc2001272
10.1101/2020.02.10.20021675
10.1056/NEJMoa2001282
10.1016/S0140-6736(20)30183-5
10.1001/jama.2012.5669
10.1038/s41422-020-0282-0
10.1056/NEJMoa2001316
10.1016/S0140-6736(20)30566-3
10.1056/NEJMc2001468
10.1038/s41586-020-2012-7
10.1001/jama.2020.1585
10.1038/s41564-020-0688-y
10.1016/S0140-6736(20)30211-7
10.1056/NEJMoa2001191
10.1101/2020.01.26.919985
10.1056/NEJMoa2001017
10.1016/S0140-6736(20)30251-8
ContentType Journal Article
Copyright The Author(s) 2020
COPYRIGHT 2020 BioMed Central Ltd.
2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2020
– notice: COPYRIGHT 2020 BioMed Central Ltd.
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s13054-020-02895-6
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Proquest Health and Medical Complete
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
Coronavirus Research Database
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

MEDLINE

MEDLINE - Academic

Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1364-8535
1466-609X
1366-609X
EndPage 9
ExternalDocumentID oai_doaj_org_article_e489f962730d4f6c93bc59a99927ef0a
PMC7192564
A627423858
32354360
10_1186_s13054_020_02895_6
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations China
United Kingdom
GeographicLocations_xml – name: China
– name: United Kingdom
GrantInformation_xml – fundername: National Major Science and Technology Projects of China
  grantid: 2020ZX09201007
  funderid: http://dx.doi.org/10.13039/501100013076
– fundername: National Natural Science Foundation of China
  grantid: 81701941; 81772046; 81971816
  funderid: http://dx.doi.org/10.13039/501100001809
– fundername: National Natural Science Foundation of China
  grantid: 81701941
– fundername: National Major Science and Technology Projects of China
  grantid: 2020ZX09201007
– fundername: National Natural Science Foundation of China
  grantid: 81772046
– fundername: National Natural Science Foundation of China
  grantid: 81971816
– fundername: ;
  grantid: 81701941; 81772046; 81971816
– fundername: ;
  grantid: 2020ZX09201007
GroupedDBID ---
0R~
29F
2WC
4.4
53G
5GY
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABUWG
ACGFS
ACJQM
ADBBV
ADUKV
AEGXH
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIAM
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
E3Z
EBD
EBLON
EBS
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
OK1
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
ROL
RPM
RSV
SJN
SMD
SOJ
SV3
TR2
U2A
UKHRP
WOQ
YOC
.6V
AAYXX
AFFHD
CITATION
-5E
-5G
-BR
3V.
ACRMQ
ADINQ
ALIPV
C24
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
AZQEC
COVID
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c607t-2634aab1d6fe2af9649b3204c14ad10b1b7ad9592bde7df4b598807ff093b4743
IEDL.DBID 7X7
ISICitedReferencesCount 233
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000531320100002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1364-8535
1466-609X
IngestDate Fri Oct 03 12:44:18 EDT 2025
Tue Nov 04 01:59:16 EST 2025
Fri Sep 05 12:39:24 EDT 2025
Tue Oct 14 12:40:55 EDT 2025
Sat Nov 29 13:19:30 EST 2025
Sat Nov 29 10:24:34 EST 2025
Thu Jan 02 22:59:27 EST 2025
Tue Nov 18 22:04:53 EST 2025
Sat Nov 29 06:02:03 EST 2025
Sat Sep 06 07:25:16 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Infection
Pneumonia
Coronavirus
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c607t-2634aab1d6fe2af9649b3204c14ad10b1b7ad9592bde7df4b598807ff093b4743
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/2404244203?pq-origsite=%requestingapplication%
PMID 32354360
PQID 2404244203
PQPubID 44362
PageCount 9
ParticipantIDs doaj_primary_oai_doaj_org_article_e489f962730d4f6c93bc59a99927ef0a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7192564
proquest_miscellaneous_2397685640
proquest_journals_2404244203
gale_infotracmisc_A627423858
gale_infotracacademiconefile_A627423858
pubmed_primary_32354360
crossref_citationtrail_10_1186_s13054_020_02895_6
crossref_primary_10_1186_s13054_020_02895_6
springer_journals_10_1186_s13054_020_02895_6
PublicationCentury 2000
PublicationDate 2020-04-30
PublicationDateYYYYMMDD 2020-04-30
PublicationDate_xml – month: 04
  year: 2020
  text: 2020-04-30
  day: 30
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Critical care (London, England)
PublicationTitleAbbrev Crit Care
PublicationTitleAlternate Crit Care
PublicationYear 2020
Publisher BioMed Central
BioMed Central Ltd
Springer Nature B.V
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: Springer Nature B.V
– name: BMC
References 2895_CR12
2895_CR23
2895_CR11
2895_CR22
2895_CR14
2895_CR13
2895_CR10
2895_CR21
2895_CR20
2895_CR3
2895_CR2
2895_CR1
2895_CR7
2895_CR6
2895_CR19
2895_CR5
VM Ranieri (2895_CR15) 2012; 307
2895_CR4
2895_CR16
2895_CR9
2895_CR18
2895_CR8
2895_CR17
References_xml – ident: 2895_CR6
  doi: 10.1016/S0140-6736(20)30154-9
– ident: 2895_CR19
  doi: 10.1101/2020.01.30.927806
– ident: 2895_CR1
  doi: 10.1056/NEJMoa2002032
– ident: 2895_CR7
  doi: 10.1056/NEJMc2001272
– ident: 2895_CR9
  doi: 10.1101/2020.02.10.20021675
– ident: 2895_CR16
– ident: 2895_CR14
– ident: 2895_CR23
  doi: 10.1056/NEJMoa2001282
– ident: 2895_CR10
  doi: 10.1016/S0140-6736(20)30183-5
– volume: 307
  start-page: 2526
  issue: 23
  year: 2012
  ident: 2895_CR15
  publication-title: JAMA
  doi: 10.1001/jama.2012.5669
– ident: 2895_CR22
  doi: 10.1038/s41422-020-0282-0
– ident: 2895_CR5
  doi: 10.1056/NEJMoa2001316
– ident: 2895_CR21
– ident: 2895_CR13
  doi: 10.1016/S0140-6736(20)30566-3
– ident: 2895_CR8
  doi: 10.1056/NEJMc2001468
– ident: 2895_CR4
  doi: 10.1038/s41586-020-2012-7
– ident: 2895_CR12
  doi: 10.1001/jama.2020.1585
– ident: 2895_CR17
  doi: 10.1038/s41564-020-0688-y
– ident: 2895_CR11
  doi: 10.1016/S0140-6736(20)30211-7
– ident: 2895_CR18
  doi: 10.1056/NEJMoa2001191
– ident: 2895_CR20
  doi: 10.1101/2020.01.26.919985
– ident: 2895_CR2
  doi: 10.1056/NEJMoa2001017
– ident: 2895_CR3
  doi: 10.1016/S0140-6736(20)30251-8
SSID ssj0017863
Score 2.6770325
Snippet Background In December 2019, coronavirus disease 2019 (COVID-19) outbreak was reported from Wuhan, China. Information on the clinical course and prognosis of...
In December 2019, coronavirus disease 2019 (COVID-19) outbreak was reported from Wuhan, China. Information on the clinical course and prognosis of COVID-19 was...
Background In December 2019, coronavirus disease 2019 (COVID-19) outbreak was reported from Wuhan, China. Information on the clinical course and prognosis of...
Abstract Background In December 2019, coronavirus disease 2019 (COVID-19) outbreak was reported from Wuhan, China. Information on the clinical course and...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 188
SubjectTerms Acute Kidney Injury - virology
Adult
Adult respiratory distress syndrome
Age Factors
Aged
Aged, 80 and over
Betacoronavirus
Body temperature
China
Comparative analysis
Coronavirus
Coronavirus Infections - diagnosis
Coronavirus Infections - mortality
Coronavirus Infections - therapy
Coronaviruses
Cough - virology
COVID-19
Critical care
Critical Care Medicine
Data collection
Disease transmission
Dyspnea
Emergency Medicine
Epidemiology
Female
Fever
Fever - virology
Genomes
Heart - virology
Hospitals
Humans
Hypertension
Illnesses
Infection
Intensive
Laboratories
Lymphopenia - virology
Male
Medical prognosis
Medical records
Medicine
Medicine & Public Health
Middle Aged
Neutrophils
Pandemics
Patient Discharge
Patient outcomes
Pneumonia
Pneumonia, Viral - diagnosis
Pneumonia, Viral - mortality
Pneumonia, Viral - therapy
Prognosis
Respiratory Distress Syndrome - virology
Retrospective Studies
Risk Factors
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Sex Factors
Thrombocytopenia - virology
Young Adult
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQhRAXxJvQgoyExIGNmsTv41JRcYAKUSi9WbbjaFeqkmpf_Q_8amac7NIUAReuazuyPWP7m52Zbwh5XWvGA7xzuTFNzLnzRe5K4XMlal7UAkB-So8--6hOTvT5ufl8rdQXxoT19MD9xh1Grk2DFWJYUfNGBsN8EMYBrqlUbIoEjQpltsbU4D9QWrJtioyWh0u4qQXP0VRCz5rI5egZSmz9v9_J1x6lmwGTN7ym6TE6vk_uDSiSTvvZPyC3YvuQ3Pk0-MkfkR8D3ecFDR1GaVDX1rRbr0C9Iu0aCtYYHRhVl7SPx4o1xf9kKQBC2nabiEMXANM388V6OaGn0y-n-VF3llcTipm8SLAEQzA7ha6uOjob6o_g5-j39cy1E5pqcz8m347ffz36kA9VF_IgC7XKK8m4c76sZRMrB1vPjWdVwUPJXV0WvvTK1UaYytdR1Q33wsAdoJqmANFwACRPyF7btfEZoaUPlfalDl4K3jimvQTr0WmDIJNJn5FyKwQbBkpyrIxxYZNpoqXtBWdBcDYJzsqMvN2NuewJOf7a-x3KdtcTybTTD6BidlAx-y8Vy8gb1AyLRx6mF9yQuQCLRPIsO5XJ362FzsjBqCcc1TBu3uqWHa6KpQVIhcmGVcEy8mrXjCMx_K2N3Rr6IGrUQvIiI097VdwtiVVMcCahRY2UdLTmcUs7nyUicQXwHj6akclWnX9N6897-vx_7Ok-uVul44h-uQOyt1qs4wtyO2xW8-XiZTrMPwEycEmo
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: SpringerLink Contemporary
  dbid: RSV
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3JjtMw1IIBIS7sS2BARkLiQKNJ4iX2sYwYcYARmsIwN8t2HFpplKCmLf_AV_OemxQyLBJc4_es2Hlr3kbI80ox7kHPpVrXIeXWZanNhUtLUfGsEmDkx_Lo07fl8bE6O9Pv-6Kwbsh2H0KSUVJHtlbyoANpK3iK7g5Gx0QqL5MroO4UDmw4mZ3uYgelkmwoj_kt3kgFxU79v8rjnxTSxWTJCxHTqIiObv7fEW6RG73hSadbSrlNLoXmDrn2rg-t3yXf-g6h59S3mNhBbVPRdr2CnQNtawoOHO2bsHZ0m8IVKoq_cSnYkLRpNwFRl2DZbxbLdTehs-nJLD1sT9NiQrH4F3syAQoWtNDV15bO-5EluB39tJ7bZkLjOO975OPR6w-Hb9J-UEPqZVau0kIybq3LK1mHwtZacu1YkXGfc1vlmctdaSstdOGqUFY1d0KD2CjrOtPMcbBh7pO9pm3CQ0Jz5wvlcuWdFLy2TDkJDqdVGu1SJl1C8uHbGd93McdhGucmejNKmu0lG7hkEy_ZyIS83OF82fbw-Cv0KySJHST2344P2uVn07OzCVzpGucWsazitfRwDi-0BWu7KEOd2YS8QIIyKCXg9bztix3gkNhvy0xlDJEroRKyP4IE7vbj5YEkTS9dOgNWGNYnFhlLyLPdMmJixlwT2jXAoKGphORZQh5sKXh3JFYwwZmElXJE26Mzj1eaxTz2Hi_BI4BNEzIZKPzHa_35Th_9G_hjcr2ITIJBu32yt1quwxNy1W9Wi275NHL7d574TdY
  priority: 102
  providerName: Springer Nature
Title Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China
URI https://link.springer.com/article/10.1186/s13054-020-02895-6
https://www.ncbi.nlm.nih.gov/pubmed/32354360
https://www.proquest.com/docview/2404244203
https://www.proquest.com/docview/2397685640
https://pubmed.ncbi.nlm.nih.gov/PMC7192564
https://doaj.org/article/e489f962730d4f6c93bc59a99927ef0a
Volume 24
WOSCitedRecordID wos000531320100002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVADU
  databaseName: BioMedCentral
  customDbUrl:
  eissn: 1364-8535
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017863
  issn: 1364-8535
  databaseCode: RBZ
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://www.biomedcentral.com/search/
  providerName: BioMedCentral
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1364-8535
  dateEnd: 20231231
  omitProxy: false
  ssIdentifier: ssj0017863
  issn: 1364-8535
  databaseCode: DOA
  dateStart: 19980101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1364-8535
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017863
  issn: 1364-8535
  databaseCode: 7X7
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1364-8535
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017863
  issn: 1364-8535
  databaseCode: BENPR
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 1364-8535
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017863
  issn: 1364-8535
  databaseCode: PIMPY
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVAVX
  databaseName: SpringerLink Contemporary
  customDbUrl:
  eissn: 1364-8535
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017863
  issn: 1364-8535
  databaseCode: RSV
  dateStart: 19970401
  isFulltext: true
  titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22
  providerName: Springer Nature
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR3bbtMw1IINIV64DwKjMhISD9RaLrbjPKFu2gQSq6oWSnmKbCehlaZk9MY_8NWc47odGWIvvERKbKc59bn63Ah5U6iEW5BzLMuqknFtQqYjYVgqCh4WApR8lx49_pT2-2oyyQb-wG3hwyq3PNEx6qKxeEZ-BJIHc7LiMHl_-YNh1yj0rvoWGrfJPrbNRjxPJzuDK0qV66QWJZIzEEtimzSj5NECeLfgDI0n9LUJJluCydXv_5tL_yGmrodQXvOjOvF09uB_AXtI7nvFlPY2mPSI3Crrx-TuuXe9PyG_fAXRC2obDPygui5os1rCj5S0qSgYeNQXaV3QTYhXWVA85qWgY9K6WZe4dA6a_3o2Xy26dNQbjthJM2Zxl2JyMNZsgiWY8EKXPxs69S1N8HX062qq6y517b6fki9np59PPjDfyIFZGaZLFsuEa22iQlZlrKtM8swkcchtxHURhSYyqS4ykcWmKNOi4kZkwFbSqgqzxHDQcQ7IXt3U5XNCI2NjZSJljRS80okyEgxSrTLUWxNpAhJtdzG3vso5Ntu4yJ21o2S-2fkcdj53O5_LgLzbrbnc1Pi4cfYxIsduJtbndg-a-ffck3tecpVV2NcoCQteSQtwWJFp0MbjtKxCHZC3iFo5chH4PKt9MgQAifW48p50LnQlVEAOWzOB-m17eItVuec-i_wKpQLyejeMKzGiri6bFcxBRVQJycOAPNvg8g6kJE4ETySMpC0sb8HcHqlnU1ebPAWLAV4akO6WHq4-69__6YuboXhJ7sWOUtGJd0j2lvNV-YrcsevlbDHvOJp3V9Uh-8en_cGw445W4G7w8XzwDe6Go_FvLdlfng
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFLZKQcCFfQkUMBKIA2M1i-04B4SGQtWq0wrRUnoztuPQSlVSZmnFX-DH8Bt5z5NMmSJ664FrvCjPedsXv4WQF6XKuAM7x4qi8owbGzOTCMtyUfK4FODkh_To3UG-taX29oqPC-RXlwuDYZWdTgyKumwc_iNfBsuDOVlpnL09-s6waxTernYtNKZsseF_nABkG71Zfw_f92Warn7YWVljbVcB5mScj1kqM26MTUpZ-dRUheSFzdKYu4SbMoltYnNTFqJIbenzsuJWFMDjeVUB9rccDC7se4lcBj2eI9jL92YAL8lV6NyWZJIzMIOiS9JRcnkEtkJwhmAN7_YEk3OGMPQL-Nsq_GEWz4Zsnrm3DeZw9eb_dpC3yI3W8ab9qaTcJgu-vkOubrahBXfJz7ZC6iF1DQa2UFOXtJmMgShPm4oCgKVtEdoRnYaw-ZLib2wKPjStm2OPS4eAbI4PhpNRj273P22zlWaXpT2Kyc9YkwqWYEIPHZ80dL9t2YLb0S-TfVP3aGhnfo98vpCTuE8W66b2DwlNrEuVTZSzUvDKZMpKANxGFeiXZ9JGJOm4Rru2ijs2EznUAc0pqaecpoHTdOA0LSPyerbmaFrD5NzZ75AZZzOx_nh40Ay_6Vadac9VUWHfpiwueSUd0OFEYQBtpLmvYhORV8jKGrUkvJ4zbbIHEIn1xnRfhhABJVREluZmgnZz88MdF-tWu470KQtH5PlsGFdixGDtmwnMQUdbCcnjiDyYys6MpCzNBM8kjORzUjVH8_xIfbAfaq_ngIhg04j0Ovk7fa1_n-mj86l4Rq6t7WwO9GB9a-MxuZ4GLYEXlktkcTyc-CfkijseH4yGT4O-oeTrRcvlb89btoI
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELdgoIkXvj8CA4yExAONlsSOYz-WQQViVBOFsTfLn7TSlExtWv4H_mp8TlrW8SEhXuu7NOeez3e9u98h9NxyQk2451IhvEup0lmq8lKnVWlpZsvg5Mf26OPDajzmJyfi6FwXf6x2X6cku54GQGmq2_0z67sjztn-IljekqYQ-kCmrEzZZXSFQiE9xOuT400eoeKMrFtlfsu3dR1F1P5fbfO5y-li4eSF7Gm8lEY3_l-cm-h675DiYadBt9AlV99Gux_6lPsd9L1HDj3FpoGCD6xqi5tlG77F4cbjENjhHpx1gbvSLmcx_L2Lg2-J62blgHUePP7VbL5cDPBk-HGSHjTHaTHA0BQMWE2BBRpdcPutwdN-lAk8Dn9ZTlU9wHHM9130efTm08HbtB_gkBqWVW1aMEKV0rll3hXKC0aFJkVGTU6VzTOd60pZUYpCW1dZT3UpgjmpvM8E0TT4NvfQTt3U7gHCuTYF1zk3mpXUK8I1C4Go4gL8VcJ0gvL17yhNj24OQzZOZYxyOJPdJsuwyTJusmQJernhOeuwPf5K_QrUY0MJuNzxg2b-VfbHXDrKhYd5RiSz1DMT5DClUMELLyrnM5WgF6BcEqxHeD2j-iaIICTgcMkhi6lzXvIE7W1RhlNvtpfX6il7q7OQwTuDvsUiIwl6tlkGTqikq12zDDTggPKS0SxB9ztt3ohEClJSwsJKtaXnWzJvr9SzacQkr0KkEB6aoMFa23--1p_39OG_kT9Fu0evR_Lw3fj9I3StiOcF8np7aKedL91jdNWs2tli_iQagR9uQ1me
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+course+and+outcome+of+107+patients+infected+with+the+novel+coronavirus%2C+SARS-CoV-2%2C+discharged+from+two+hospitals+in+Wuhan%2C+China&rft.jtitle=Critical+care+%28London%2C+England%29&rft.au=Wang%2C+Dawei&rft.au=Yin%2C+Yimei&rft.au=Hu%2C+Chang&rft.au=Liu%2C+Xing&rft.date=2020-04-30&rft.pub=BioMed+Central+Ltd&rft.issn=1364-8535&rft.volume=24&rft.issue=1&rft_id=info:doi/10.1186%2Fs13054-020-02895-6&rft.externalDocID=A627423858
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1364-8535&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1364-8535&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1364-8535&client=summon